Literature DB >> 20959603

von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models.

Alexander Brill1, Tobias A Fuchs, Anil K Chauhan, Janie J Yang, Simon F De Meyer, Maria Köllnberger, Thomas W Wakefield, Bernhard Lämmle, Steffen Massberg, Denisa D Wagner.   

Abstract

Deep vein thrombosis (DVT) and its complication, pulmonary embolism, are frequent causes of disability and mortality. Although blood flow disturbance is considered an important triggering factor, the mechanism of DVT initiation remains elusive. Here we show that 48-hour flow restriction in the inferior vena cava (IVC) results in the development of thrombi structurally similar to human deep vein thrombi. von Willebrand factor (VWF)-deficient mice were protected from thrombosis induced by complete (stasis) or partial (stenosis) flow restriction in the IVC. Mice with half normal VWF levels were also protected in the stenosis model. Besides promoting platelet adhesion, VWF carries Factor VIII. Repeated infusions of recombinant Factor VIII did not rescue thrombosis in VWF(-/-) mice, indicating that impaired coagulation was not the primary reason for the absence of DVT in VWF(-/-) mice. Infusion of GPG-290, a mutant glycoprotein Ibα-immunoglobulin chimera that specifically inhibits interaction of the VWF A1 domain with platelets, prevented thrombosis in wild-type mice. Intravital microscopy showed that platelet and leukocyte recruitment in the early stages of DVT was dramatically higher in wild-type than in VWF(-/-) IVC. Our results demonstrate a pathogenetic role for VWF-platelet interaction in flow disturbance-induced venous thrombosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959603      PMCID: PMC3056477          DOI: 10.1182/blood-2010-05-287623

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice.

Authors:  T N Mayadas; R C Johnson; H Rayburn; R O Hynes; D D Wagner
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

2.  Factor IXa and von Willebrand factor modify the inactivation of factor VIII by activated protein C.

Authors:  M E Rick; N L Esmon; D M Krizek
Journal:  J Lab Clin Med       Date:  1990-04

3.  Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease.

Authors:  J L Miller; D Cunningham; V A Lyle; C N Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Inducible secretion of large, biologically potent von Willebrand factor multimers.

Authors:  L A Sporn; V J Marder; D D Wagner
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

5.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

6.  The structure and growth of valve-pocket thrombi in femoral veins.

Authors:  S Sevitt
Journal:  J Clin Pathol       Date:  1974-07       Impact factor: 3.411

7.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

Authors:  B Dahlbäck; M Carlsson; P J Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

8.  Importance of platelets in experimental venous thrombosis in the rat.

Authors:  J M Herbert; A Bernat; J P Maffrand
Journal:  Blood       Date:  1992-11-01       Impact factor: 22.113

9.  Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor.

Authors:  S D Russell; G J Roth
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

10.  Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.

Authors:  Shahrokh Falati; Qingde Liu; Peter Gross; Glenn Merrill-Skoloff; Janet Chou; Erik Vandendries; Alessandro Celi; Kevin Croce; Barbara C Furie; Bruce Furie
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  162 in total

1.  Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl(3)-induced occlusive thrombus formation in the inferior vena cava of mice.

Authors:  M V Joglekar; Jerry Ware; Jin Xu; Malinda E C Fitzgerald; Theodore Kent Gartner
Journal:  Platelets       Date:  2012-06-21       Impact factor: 3.862

2.  Von Willebrand factor is reversibly decreased during torpor in 13-lined ground squirrels.

Authors:  Scott Cooper; Shawn Sell; Luke Nelson; Jennifer Hawes; Jacob A Benrud; Bridget M Kohlnhofer; Bradley R Burmeister; Veronica H Flood
Journal:  J Comp Physiol B       Date:  2016-01       Impact factor: 2.200

Review 3.  Mouse models of cancer-associated thrombosis.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Thromb Res       Date:  2017-12-29       Impact factor: 3.944

4.  Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice.

Authors:  Kimberly Martinod; Melanie Demers; Tobias A Fuchs; Siu Ling Wong; Alexander Brill; Maureen Gallant; Jing Hu; Yanming Wang; Denisa D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

5.  Bernard-Soulier syndrome.

Authors:  Michael C Berndt; Robert K Andrews
Journal:  Haematologica       Date:  2011-03       Impact factor: 9.941

6.  Factor XIII activity mediates red blood cell retention in venous thrombi.

Authors:  Maria M Aleman; James R Byrnes; Jian-Guo Wang; Reginald Tran; Wilbur A Lam; Jorge Di Paola; Nigel Mackman; Jay L Degen; Matthew J Flick; Alisa S Wolberg
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

Review 7.  Animal models of venous thrombosis.

Authors:  Hassan Albadawi; Avery A Witting; Yash Pershad; Alex Wallace; Andrew R Fleck; Peter Hoang; Ali Khademhosseini; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 8.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

9.  Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis.

Authors:  Sanjana Dayal; Katina M Wilson; David G Motto; Francis J Miller; Anil K Chauhan; Steven R Lentz
Journal:  Circulation       Date:  2013-02-20       Impact factor: 29.690

10.  P-selectin can promote thrombus propagation independently of both von Willebrand factor and thrombospondin-1 in mice.

Authors:  P Prakash; M K Nayak; A K Chauhan
Journal:  J Thromb Haemost       Date:  2017-02-03       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.